![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, September 02, 2021 1:32:22 PM
We could get ABIVERTINIB Covid cytokine storm "prevention" results from the US and Brazil later this month. If it is successful it is another enormous unmet need.
The next important treatment news could be about COVIDROPS. These nasal drops would be a treatment game changer. They are undergoing interesting trials in several jurisdictions including the UK.
COVIMSC, ABIVERTINIB and COVIDROPS each have enormous worldwide potential. Each would warrant EUA approvals and would likely attract worldwide marketing partnerships.
These near term results plus the PSS arbitration results and the pivotal SP-102 results make for an interesting Q4 2021 and Q1 2022.
"The refusal of the real is the number one dogma of our time" Rene Girard
Recent SRNE News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM